These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 23166707

  • 1. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.
    Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Lencina C, Lévêque M, Braniste V, Ménard S, Théodorou V, Houdeau E.
    PLoS One; 2012; 7(11):e49547. PubMed ID: 23166707
    [Abstract] [Full Text] [Related]

  • 2. Intestinal protease-activated receptor-2 and fecal serine protease activity are increased in canine inflammatory bowel disease and may contribute to intestinal cytokine expression.
    Maeda S, Ohno K, Uchida K, Igarashi H, Goto-Koshino Y, Fujino Y, Tsujimoto H.
    J Vet Med Sci; 2014 Aug; 76(8):1119-27. PubMed ID: 24829081
    [Abstract] [Full Text] [Related]

  • 3. A new soy germ fermented ingredient displays estrogenic and protease inhibitor activities able to prevent irritable bowel syndrome-like symptoms in stressed female rats.
    Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Houdeau E, Théodorou V.
    Clin Nutr; 2013 Feb; 32(1):51-8. PubMed ID: 22727545
    [Abstract] [Full Text] [Related]

  • 4. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
    Algieri F, Zorrilla P, Rodriguez-Nogales A, Garrido-Mesa N, Bañuelos O, González-Tejero MR, Casares-Porcel M, Molero-Mesa J, Zarzuelo A, Utrilla MP, Rodriguez-Cabezas ME, Galvez J.
    J Ethnopharmacol; 2013 Apr 19; 146(3):750-9. PubMed ID: 23395625
    [Abstract] [Full Text] [Related]

  • 5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G.
    Dan Med J; 2015 Jan 19; 62(1):B4973. PubMed ID: 25557335
    [Abstract] [Full Text] [Related]

  • 6. Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats.
    Róka R, Ait-Belgnaoui A, Salvador-Cartier C, Garcia-Villar R, Fioramonti J, Eutamène H, Bueno L.
    Gut; 2007 Aug 19; 56(8):1072-8. PubMed ID: 17309885
    [Abstract] [Full Text] [Related]

  • 7. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L.
    Gut; 2008 May 19; 57(5):591-9. PubMed ID: 18194983
    [Abstract] [Full Text] [Related]

  • 8. Chronic colitis-induced visceral pain is associated with increased anxiety during quiescent phase.
    Salameh E, Meleine M, Gourcerol G, do Rego JC, do Rego JL, Legrand R, Breton J, Aziz M, Guérin C, Coëffier M, Savoye G, Marion-Letellier R.
    Am J Physiol Gastrointest Liver Physiol; 2019 Jun 01; 316(6):G692-G700. PubMed ID: 30735453
    [Abstract] [Full Text] [Related]

  • 9. Protease activated receptor 2: a new target for IBS treatment.
    Bueno L.
    Eur Rev Med Pharmacol Sci; 2008 Aug 01; 12 Suppl 1():95-102. PubMed ID: 18924448
    [Abstract] [Full Text] [Related]

  • 10. Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid.
    Chiu CT, Kuo SN, Hung SW, Yang CY.
    Molecules; 2017 May 30; 22(6):. PubMed ID: 28556814
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of protease-activated receptor 2 protects against experimental colitis.
    Lohman RJ, Cotterell AJ, Suen J, Liu L, Do AT, Vesey DA, Fairlie DP.
    J Pharmacol Exp Ther; 2012 Feb 30; 340(2):256-65. PubMed ID: 22028393
    [Abstract] [Full Text] [Related]

  • 12. Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD.
    Brenna Ø, Furnes MW, Drozdov I, van Beelen Granlund A, Flatberg A, Sandvik AK, Zwiggelaar RT, Mårvik R, Nordrum IS, Kidd M, Gustafsson BI.
    PLoS One; 2013 Feb 30; 8(1):e54543. PubMed ID: 23382912
    [Abstract] [Full Text] [Related]

  • 13. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model.
    Woo JK, Choi S, Kang JH, Kim DE, Hurh BS, Jeon JE, Kim SY, Oh SH.
    BMC Complement Altern Med; 2016 Dec 03; 16(1):498. PubMed ID: 27912750
    [Abstract] [Full Text] [Related]

  • 14. Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
    Choi KC, Cho SW, Kook SH, Chun SR, Bhattarai G, Poudel SB, Kim MK, Lee KY, Lee JC.
    J Ethnopharmacol; 2016 Feb 17; 179():55-65. PubMed ID: 26721217
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease.
    Elli L, Ciulla MM, Busca G, Roncoroni L, Maioli C, Ferrero S, Bardella MT, Bonura A, Paliotti R, Terrani C, Braidotti P.
    Lab Invest; 2011 Mar 17; 91(3):452-61. PubMed ID: 21042292
    [Abstract] [Full Text] [Related]

  • 16. A moderately elevated soy protein diet mitigates inflammatory changes in gut and in bone turnover during chronic TNBS-induced inflammatory bowel disease.
    Metzger CE, Narayanan SA, Zawieja DC, Bloomfield SA.
    Appl Physiol Nutr Metab; 2019 Jun 17; 44(6):595-605. PubMed ID: 30352170
    [Abstract] [Full Text] [Related]

  • 17. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
    Du L, Long Y, Kim JJ, Chen B, Zhu Y, Dai N.
    Dig Dis Sci; 2019 Mar 17; 64(3):729-739. PubMed ID: 30446929
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis.
    Zhu T, Liu TJ, Shi YY, Zhao Q.
    Int J Mol Med; 2015 May 17; 35(5):1213-8. PubMed ID: 25813397
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
    Xu J, Zheng C, Huang Y, Liang Y.
    Chin Med J (Engl); 2014 May 17; 127(12):2368-75. PubMed ID: 24931258
    [Abstract] [Full Text] [Related]

  • 20. Protease-activated receptor-2 activation: a major actor in intestinal inflammation.
    Hyun E, Andrade-Gordon P, Steinhoff M, Vergnolle N.
    Gut; 2008 Sep 17; 57(9):1222-9. PubMed ID: 18460552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.